Clinical Trials Browser

Phase 3 × Carcinoma, Renal Cell × durvalumab × Clear all

NCT05043090 2025-05-08

SAMETA

Phase 3 Active not recruiting

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT03288532 2020-09-07

RAMPART

Phase 3 Recruiting

Carcinoma, Renal Cell